Central Trust Co (CTTC) 0.2395 $CTTC Calmare

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Central Trust Co (CTTC) 0.2395 $CTTC

Calmare Therapeutics Receives Final Signatures on Supply Order Contract Documents
BusinessWire - Thu May 05, 10:31AM CDT
Calmare Therapeutics Incorporated (OTC: CTTC) (CTI), the Calmare(R) chronic pain and wound care company, has received final signatures on the supply order contract (#V797P-4300B) (the "Contract". CTI may now receive and fulfill medical product orders, as per the terms and conditions of the Contract.

Calmare Therapeutics Reports Year-End 2015 Results
ACCESSWIRE - Tue Apr 19, 1:54PM CDT
Fourth Quarter: Revenues Up 8%; Device Sales Up 150%; Net Loss Per Share Flat; Year end: Revenues Down 15%; Gross Margin Up 5%; Net Loss Per Share Down $ .02

InnerWorkings (INWK) in Focus: Stock Jumps 5.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 8:18AM CST
InnerWorkings Inc. (INWK) was a big mover last session, as the company saw its shares rise over 5% on the day.
INWK: 8.41 (+0.04)

L.B. Foster Boosts Inorganic Growth on TEW Engineering Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 4:39PM CST
Premium railroads manufacturing company L.B. Foster Co. (FSTR) has recently strengthened its automated and international solutions' trade with the acquisition of TEW Engineering Ltd.
FSTR: 12.65 (+0.17), MTL: 1.77 (unch), CCRN: 14.42 (-0.02)

Calmare Therapeutics to Present at the Ld Micro "Main Event" Microcap Growth Conference
ACCESSWIRE - Wed Dec 03, 9:26AM CST
Fairfield, CT / ACCESSWIRE / December 3, 2014 / Calmare Therapeutics Incorporated, (OTCQX: CTTC) (CTI), the pain mitigation company, will present at the 7th Annual LD Micro "Main Event" Micro-Cap Growth Conference on Thursday, December 4 at 7:30 AM PT/10:30 AM EST. The conference will be held at the Luxe Sunset Bel Air Hotel, in Los Angeles, California.

Calmare Therapeutics Reports Third Quarter 2014 Results
ACCESSWIRE - Fri Nov 21, 2:57PM CST
Investor Conference Call: Monday, November 24, 2014 at 10:00 a.m. EST Dial-in: (866) 952-1908 | Conference ID: CTI

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CelluPro Earns Global Recognition with EXCiPACT Certification

Updated Category News Views 2

Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...

Continue Reading
Aluminum Refractory Market to Hit $2.73B by 2031

Updated Category News Views 5

Riding the Aluminum Refractory Wave to 2031 Look, when you want to throw some cash in a market that's gaining steam, aluminum refractory materials might not be your first pick. But here's the thing: it's charging ahead to a cool $2.73 billion by 2031. And if you're keeping tabs on the likes of RHI Magnesita and Calderys, this is a sector that deserves a once-over. What...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 3

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 1

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 6

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 1

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Indiana Fire Safety: The Importance of Regular Inspections

Updated Category News Views 3

Everybody thinks of fire extinguishers as those red cans hanging quietly on walls, but there's more to them than meets the eye. In Central Indiana, these devices are a literal lifeline, and neglecting their upkeep is playing with fire—literally. What Makes Monthly Checks a Big Deal? Fire extinguishers aren't just there for decoration. They're critical safety gear. This...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
FOTON Accelerates Global Push with European Focus

Updated Category News Views 4

The Road to Global Dominance Ever feel like someone’s racing past you while others try to catch up? That’s FOTON in the relentless world of commercial vehicles. This juggernaut of a company isn't just satisfied with leading the pack; they’ve got their eyes set on redefines the game, especially with their new moves in Europe. A Shift in Strategy Right now, the...

Continue Reading
Huayan Robotics Hits IMTS 2026 with Cutting-Edge Tech

Updated Category News Views 2

Unveiling Robotics Prowess at IMTS 2026 Every two years, the world of manufacturing gathers at the International Manufacturing Technology Show (IMTS), and this time, the spotlight is on Huayan Robotics. With the event drawing over 90,000 professionals, everybody with a finger on the pulse of intelligent manufacturing will be keen to see what Huayan has up its sleeve. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Recycling Equipment: Market Growth Insights

Updated Category News Views 105

The Growing Recycling Equipment Market The Recycling Equipment Market is on a remarkable trajectory, with expectations to soar from USD 29.46 billion in 2023 to USD 48.07 billion by 2032. This promising growth reflects a compound annual growth rate (CAGR) of 5.59% between 2024 and 2032. A global awakening to environmental issues is driving industries and governments alike...

Continue Reading
Callinex Mines Expands Exploration Efforts at Pt. Leamington

Updated Category News Views 99

Callinex Mines Receives Exploration Permit for Point Leamington Project Callinex Mines Inc., a prominent player in the base and precious metals sector, has recently secured a two-year exploration permit for its Pt. Leamington Project. This exciting development comes as the company aims to enhance its mineral resource base, specifically targeting the rich deposits of gold,...

Continue Reading
Exploring Oncology's Rapid Evolution and Oncolytics' Potential

Updated Category News Views 102

Oncology Approvals and Their Impact The landscape of oncology treatment is undergoing a remarkable transformation. Regulatory bodies like the FDA are not only approving new drugs but actively reshaping the future of cancer therapies. Recently, we've witnessed a surge in approvals, with over 50 new oncology treatments being authorized, signifying a pivotal change in...

Continue Reading
Oportun Successfully Launches $425 Million Asset-Backed Notes

Updated Category News Views 139

Oportun's Latest $425 Million Financing Success Oportun has recently achieved a significant milestone by successfully issuing $425 million in asset-backed securities. This accomplishment highlights the company's continual growth and robust position in the financial services sector. Understanding the Transaction This transaction comprised revolving fixed-rate notes backed...

Continue Reading
Steep Decline in CEO Confidence Signals Economic Challenges

Updated Category News Views 206

Significant Drop in CEO Confidence in Recent Survey The Conference Board recently reported a dramatic decline in the Measure of CEO Confidence, reflecting a stark shift in the sentiment among business leaders. In Q2 2025, the metric plunged by 26 points to a mere 34, marking the lowest level since late 2022. This decline is notable as it represents the most significant...

Continue Reading